New York, Feb. 7 – Citigroup Global Markets Holdings Inc. priced $10 million of 15.6% autocallable phoenix securities due Jan. 27, 2025 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a coupon of 15.6%, paid monthly, if the ETF closes at or above its 80% coupon barrier on the related valuation date, plus any previously unpaid coupons.
They will be called automatically at par if the closing price of the underlying ETF is greater than or equal to its initial price on any monthly review date.
The payout at maturity will be par if the ETF finishes at or above its 80% final barrier.
Otherwise, investors will lose 1.25% for every 1% that the ETF declines beyond 20%.
The notes are guaranteed by Citigroup Inc.
Citigroup Global Markets Inc. is the agent.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Autocallable phoenix securities
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $10 million
|
| Maturity: | Jan. 27, 2025
|
| Coupon: | 15.6%, paid monthly, if the ETF closes at or above its 80% coupon barrier on the related valuation date, plus any previously unpaid coupons
|
| Price: | Par
|
| Payout at maturity: | If ETF finishes at or above final barrier, par; otherwise, lose 1.25% for every 1% that the ETF declines beyond 20%
|
| Call: | Automatically at par if the closing price of the underlying ETF is greater than or equal to its initial price on any monthly review date
|
| Initial level: | $87.05
|
| Final barrier: | $69.64, 80% of initial level
|
| Coupon barrier: | $69.64, 80% of initial level
|
| Strike date: | Jan. 19
|
| Pricing date: | Jan. 22
|
| Settlement date: | Jan. 25
|
| Agent: | Citigroup Global Markets Inc.
|
| Fees: | 0.1%
|
| Cusip: | 17291LCK9
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
